BARCO NV How did we achieve this? 'It's a combination of technological skill, market understanding, good partnerships and education', according to Geert Carrein, Barco Healthcare's VP Strategic Marketing.
'As a company, we never lost our focus on clinical outcomes. We launched special display systems that were designed and validated to improve clinical outcomes.'Barco's first dedicated mammography display system, based on CRT technology, was introduced in 1999. We continued to build on this, bringing new technologies such as LCD, DuraLight and Per Pixel Uniformity to further enhance image quality and improve clinical workflow.
Barco launched the first display (Mammo Tomosynthesis 5MP), cleared by the FDA, for digital breast tomosynthesis. The new RapidFrame™ technology that came along with it was proven to increase detection of small details in moving images by 10%. Our latest innovation (Coronis Uniti®) has even proven to increase detection by up to 30%!1
But it's not only the technical innovations that made a difference. We also believed we had another part to play: i.e. to educate the market and create awareness around the importance of display technology and its impact on diagnostic accuracy.
''We've always supported and invested in education of the market. Together with our partners, we have supported countless workshops across the globe that educated thousands of radiologists on digital mammography.'1Tom Kimpe and Albert Xthona. 'Quantification of detection probability of microcalcifications at increased display luminance levels.' Breast Imaging. Springer Berlin Heidelberg, 2012. 490-497.
Attachments
- Original document
- Permalink
Disclaimer
Barco NV published this content on 17 April 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 17 April 2018 07:46:02 UTC
